Risk Evaluation and Mitigation Strategy in the US: does it reduce opioid-associated mortality rate?

Takeaway

  • Mortality rates associated with extended-release and long-acting (ER/LA) opioid analgesics have reduced following implementation of Risk Evaluation and Mitigation Strategy (REMS).

Why this matters

  • Mortality rates attributed to opioid overdose are high across the US – establishing the value of REMS in reducing it can help structure healthcare systems.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.